Abu Dhabi hospital operator PureHealth's turns in healthy Q1-2025 revenues

ADX-listed company is now 'fully deleveraged' even as expansion continues

Last updated:
1 MIN READ
Stock-PureHealth
PureHealth's Q1-25 net profit gain was at 3% as the group continued its hospital capacity expansion schedule.
Supplied

Dubai: Abu Dhabi headquartered PureHealth’s Q1-2025 revenue gains have come up nice and healthy, up 8% to Dh6.6 billion. The company, which operates hospitals and healthcare services, had a net profit of Dh505 million through a 3% increase.

PureHealth currently operates 5,500 hospital beds, and its patient interactions through the first three months came to 2.5 million. It also has overseas interests in the US and UK through strategic equity investments.

On the profit side, "Some margin pressure was experienced in the hospitals segment due to expansion activity, which is expected to further cement the group’s position as a market leader and contribute to long-term profitability," said a statement. "Net income margin contracted slightly by 0.3 percentage points yoy to 7.7%."

The revenue growth was brought on by 'robust' performances in the hospital and insurance segments with Purehealth also owning the insurer Daman).

"The hospital segment growth was driven by rising patient volumes, while the insurance segment continued its growth momentum through high renewal rates and expansion in under-penetrated segments," said a statement.

Zero debt

On the financials, PureHealth emerged out of the reporting period with stronger fundamentals. “We concluded the first quarter fully deleveraged, significantly enhancing our financial flexibility,” said Shaista Asif, Group CEO. “This robust financial position enables strategic re-investments and provides a strong foundation for scaling specialized healthcare services and improving care delivery across our network.”

The company's latest overseas deal was the 60% stake buy in Hellenic Healthcare Group, the biggest privately owned healthcare provider in Greece and Cyprus.

PureHealth has secured 'necessary clearances to proceed with the acquisition, and additional regulatory reviews are currently underway', said a statement.

Sign up for the Daily Briefing

Get the latest news and updates straight to your inbox